FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyÐ¢s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.
Past Team (3)Update
Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in...
Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk...
They are a division of Fidelity Investments, one of the worldâ€™s leading providers of financial...
Venture capital Firm
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
100 Acorn Park Drive
Cambridge, MA 02140